<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medulloblastoma treatment optimization &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/medulloblastoma-treatment-optimization/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 05 Nov 2025 20:22:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Medulloblastoma treatment optimization &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Data-Driven Risk Stratification Optimizes Childhood Brain Tumor Therapy, Minimizing Side Effects</title>
		<link>https://bioengineer.org/data-driven-risk-stratification-optimizes-childhood-brain-tumor-therapy-minimizing-side-effects/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 05 Nov 2025 20:22:02 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Data-driven risk stratification]]></category>
		<category><![CDATA[Medulloblastoma treatment optimization]]></category>
		<category><![CDATA[Pediatric oncology advancements]]></category>
		<category><![CDATA[Precision medicine in neuro-oncology]]></category>
		<category><![CDATA[Reducing cancer therapy side effects]]></category>
		<guid isPermaLink="false">https://bioengineer.org/data-driven-risk-stratification-optimizes-childhood-brain-tumor-therapy-minimizing-side-effects/</guid>

					<description><![CDATA[In a landmark advancement that could transform pediatric neuro-oncology, researchers at St. Jude Children’s Research Hospital have meticulously analyzed data from nearly 900 children diagnosed with medulloblastoma, one of the most common malignant brain tumors in childhood. By integrating genomic, molecular, and clinical survival data from three major clinical trials, the team developed a novel [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">292173</post-id>	</item>
	</channel>
</rss>
